MMP9 and cancer: These findings suggest that pKAL-induced anti-cancer effects might not be closely associated with JAK2/STAT3 signaling, while JAK2 inhibited STAT3 activity and the expressions of Oct 3/4, β-catenin, and MMP-9 of RT-R-MDA-MB-231 cells.